Tratamento da candidíase vulvovaginal de repetição: revisão integrativa

Abstract

Recurrent Vulvovaginal Candidiasis (RVVC) is a common condition that affects the quality of life of women, caused by the fungus of the genus Candida. It is characterized by the incidence of vulvovaginal infection three or more times in one year. This integrative review aims to analyze the therapeutic approaches currently available for RVVC. A literature search was carried out in the Scielo, Virtual Health Library and Pubmed databases, including studies in English and Portuguese, from 2010 to 2023. The results obtained show that conventional treatments, such as azoles and polyenes, are frequently prescribed, but antifungal resistance may limit their long-term effectiveness. Furthermore, alternative approaches, such as photodynamic therapy and the use of natural products, have demonstrated some effectiveness, offering additional therapeutic options. In summary, the importance of a multifaceted approach to the treatment of RVVC is highlighted, which includes not only pharmacological therapy, but also lifestyle changes and complementary approaches. Identifying effective and personalized strategies for each patient is critical to improving clinical outcomes for women affected by RVVC.